NDC product
Allegra-D Allergy and Congestion
NDC 41167-4320 · Chattem, Inc.
Key facts
| Product NDC | 41167-4320 |
|---|---|
| Proprietary name | Allegra-D Allergy and Congestion |
| Nonproprietary name | fexofenadine hydrochloride and pseudoephedrine hydrochloride |
| Substances | FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE |
| Dosage form | TABLET, FILM COATED, EXTENDED RELEASE |
| Route | ORAL |
| Labeler | Chattem, Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | NDA |
| Application number | NDA021704 |
| Pharmacologic classes | Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC] |
| Marketing start | Mar 3, 2011 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: